Duke Cancer Institue is a clinical research site located in Durham, North Carolina, United States 27705.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Duke Cancer Institue has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Myelofibrosis.
Sponsors: Karyopharm Therapeutics Inc.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke Cancer Institue has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke Cancer Institue has 1 clinical trials on record, with 1 currently active. Their work covers Myelofibrosis.
Duke Cancer Institue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.